Patent Assignment
Reel/Frame 049081/0335
Security Interest
Recorded: 2019-05-03
Pages: 43
Assignors
GOSSAMER BIO, INC.
Executed: 2019-05-02
GOSSAMER BIO SERVICES, INC.
Executed: 2019-05-02
GB001, INC.
Executed: 2019-05-02
GB002, INC.
Executed: 2019-05-02
GB003, INC.
Executed: 2019-05-02
GB004, INC.
Executed: 2019-05-02
GB005, INC.
Executed: 2019-05-02
GB006, INC.
Executed: 2019-05-02
GB007, INC.
Executed: 2019-05-02
Assignee
MIDCAP FINANCIAL TRUST, AS AGENT
7255 WOODMONT AVE., SUITE 200, C/O MIDCAP FINANCIAL SERVICES, LLC, AS SERVICER, BETHESDA, MARYLAND, 20814
Covered Properties
(40)
Crystal of Quinoline Derivative
Application:
16/302,553 →
Publication:
US US20190276405A1
TREATMENT OF ASTHMA PATIENTS HAVING HIGH BASELINE FeNO LEVELS
Application:
62/809,255 →
Inhibitors of the TEC Kinase Enzyme Family
Application:
15/577,136 →
Publication:
US US20180179210A1
New Benzimidazoles Derivatives as Tec Kinases Family Inhibitors
Heterocyclic Tec-Family Kinase Inhibitors
Application:
15/772,916 →
Publication:
US US20200247808A1
Spirocyclic Containing Compounds and Pharmaceutical Uses Thereof
Solid Forms of (Z)-4-(5-((3-Benzyl-4-Oxo-2-Thioxothiazolidin-5-Ylidene)Methyl)Furan-2-Yl)Benzoic Acid
Compounds for Modulating Integrin CD11B/CD18
Quinolines and Their Therapeutic Use
Quinolines and Their Therapeutic Use
Quinolines and Their Therapeutic Use
Indoles and Their Therapeutic Use
PFKFB3 Inhibitor and Methods of Use as an Anti-Cancer Therapeutic
PFKFB3 Inhibit and Methods of Use as an Anti-Cancer Therapeutic
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Selective Inhibitors of Tec and Src Protein Kinase Families
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Compounds and Methods for Regulating Integrins
Compounds for Modulating Integrin CD11B/CD18
Compounds for Modulating Integrin CD11B/CD18
Compounds and Methods for Regulating Integrins
Compounds and Methods for Regulating Integrins
Pyrazole Compounds as CRTH2 Antagonists
Pyrazole Compounds as CRTH2 Antagonists
Pyrazole Compounds as CRTH2 Antagonists
Process for preparing [4,6-bis-dimethylamino-2-[4-(4-trifluoromethylbenzoylamino)benzyl]pyrimidin-5-yl]acetic acid
Pyrimidine Derivatives Useful for the Treatment of Diseases Mediated by CRTH2
Pyrimidine Derivatives Useful for the Treatment of Diseases Mediated by CRTH2
Imidazo[1,2-C]Pyrimidinylacetic Acid Derivatives
Particulates of a CRTH2 Antagonist
Amine Salts of a CRTH2 Antagonist
2-S-Benzyl Substituted Pyrimidines as CRTH2 Antagonists
Alkylthio Pyrimidines as CRTH2 Antagonists
Isotopically Enriched Pyrimidin-5-Yl Acetic Acid Derivatives as CRTH2 Antagonists
PFKFB3 Inhibitor and Methods of Use as an Anti-Cancer Therapeutic
PCT:
PCT/US2013/031159 ↗
Benzimidazole Compounds as Kinase Inhibitors
PCT:
PCT/US2018/047353 ↗
Heterocyclic Integrin Agonists
PCT:
PCT/US2017/068825 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 12, 2008
From: CRAMP, MICHAEL COLIN; ARIENZO, ROSA; HYND, GEORGE; CRACKETT, PETER
To: ARGENTA DISCOVERY LIMITED
Reel/Frame 021373/0787 →
Assignment of Assignor's Interest
Feb 18, 2010
From: MONTANA, JOHN GARY; FINCH, HARRY; HYND, GEORGE; CRAMP, MICHAEL COLIN
To: ARGENTA ORAL THERAPEUTICS LIMITED
Reel/Frame 023955/0426 →
Change of Name
Jun 30, 2010
From: ARGENTA ORAL THERAPEUTICS LIMITED
To: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
Reel/Frame 024614/0792 →
Assignment of Assignor's Interest
Oct 11, 2010
From: ARGENTA DISCOVERY LIMITED
To: ARGENTA ORAL THERAPEUTICS LIMITED
Reel/Frame 025118/0750 →
Change of Name
Oct 14, 2010
From: ARGENTA ORAL THERAPEUTICS LIMITED
To: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
Reel/Frame 025136/0739 →
Assignment of Assignor's Interest
Jan 3, 2011
From: HYND, GEORGE; MONTANA, JOHN GARY; FINCH, HARRY; ARIENZO, ROSA
To: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
Reel/Frame 025571/0707 →
Assignment of Assignor's Interest
Oct 28, 2013
From: LAURENT, ALAIN; ROSE, YANNICK; MORRIS, STEPHEN; JAQUITH, JAMES B
To: PHARMASCIENCE INC.
Reel/Frame 031486/0242 →
Assignment of Assignor's Interest
Jun 24, 2014
From: GUPTA, VINEET; ARNAOUT, M. AMIN
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 033170/0543 →
Assignment of Assignor's Interest
Nov 26, 2014
From: LAURENT, ALAIN; ROSE, YANNICK; MORRIS, STEPHEN; JAQUITH, JAMES
To: PHARMASCIENCE, INC.
Reel/Frame 034268/0584 →
Assignment of Assignor's Interest
Nov 28, 2014
From: LAURENT, ALAIN; ROSE, YANNICK; JAQUITH, JAMES B.
To: PHARMASCIENCE, INC.
Reel/Frame 034276/0699 →
Assignment of Assignor's Interest
Jan 5, 2015
From: LAURENT, ALAIN; ROSE, YANNICK
To: PHARMASCIENCE, INC.
Reel/Frame 034636/0985 →
Assignment of Assignor's Interest
Apr 16, 2015
From: TAPOLSKY, GILLES H.; CHAND, POORAN
To: ADVANCED CANCER THERAPEUTICS, LLC
Reel/Frame 035427/0731 →
Assignment of Assignor's Interest
Jun 16, 2017
From: LAURENT, ALAIN; ROSE, YANNICK
To: PHARMASCIENCE, INC.
Reel/Frame 042730/0353 →
Assignment of Assignor's Interest
Sep 27, 2017
From: TAPOLSKY, GILLES H.; CHAND, POORAN
To: ADVANCED CANCER THERAPEUTICS, LLC
Reel/Frame 043716/0308 →
Assignment of Assignor's Interest
Jun 1, 2018
From: ADVANCED CANCER THERAPEUTICS, LLC
To: GB ACT, INC.
Reel/Frame 045962/0268 →
Assignment of Assignor's Interest
Jun 5, 2018
From: LAURENT, ALAIN; ROSE, YANNICK; MORRIS, STEPHEN J.
To: PHARMASCIENCE INC.
Reel/Frame 045990/0935 →
Assignment of Assignor's Interest
Jan 11, 2019
From: PHARMASCIENCE INC.
To: GB005, INC.
Reel/Frame 047976/0794 →
Assignment of Assignor's Interest
Jan 11, 2019
From: PHARMASCIENCE INC.
To: GB005, INC.
Reel/Frame 047977/0113 →
Assignment of Assignor's Interest
Jan 11, 2019
From: LAURENT, ALAIN; ROSE, YANNICK; MORRIS, STEPHEN J.
To: PHARMASCIENCE INC.
Reel/Frame 047977/0067 →
Assignment of Assignor's Interest
Jan 11, 2019
From: LAURENT, ALAIN; ROSE, YANNICK; MORRIS, STEPHEN J.
To: PHARMASCIENCE INC.
Reel/Frame 047975/0922 →
Assignment of Assignor's Interest
Jan 23, 2019
From: PHARMASCIENCE INC.
To: GB005, INC.
Reel/Frame 048113/0842 →
Assignment of Assignor's Interest
Feb 1, 2019
From: PHARMASCIENCE INC.
To: GB005, INC.
Reel/Frame 048223/0642 →
Assignment of Assignor's Interest
Feb 4, 2019
From: PHARMASCIENCE INC.
To: GB005, INC.
Reel/Frame 048250/0595 →
Assignment of Assignor's Interest
Apr 3, 2019
From: PHARMASCIENCE, INC.
To: GB005, INC.
Reel/Frame 048786/0128 →
Assignment of Assignor's Interest
Apr 3, 2019
From: PHARMASCIENCE, INC.
To: GB005, INC.
Reel/Frame 048786/0087 →